 "Dr Reddy's Q1 net down 76% at Rs 154 cr")
Dr Reddy’s Laboratories Ltd has launched nystatin and triamcinolone acetonide cream, USP, in the US market, approved by the US Food & Drug Administration (FDA). The new product is the generic equivalent of Taro Pharmacueticals’ nystatin and triamcinolone acetonide cream - a combination of an antifungal medication and a synthetic corticosteroid in a cream used to treat fungal skin infections
The generic had US sales of approximately $ 119 million MAT for the most recent twelve months ended in October 2016, according to IMS Health.
Dr Reddy’s nystatin and triamcinolone acetonide cream is available in tube sizes of 15 g, 30 g and 60g.
